This document provides information on the working of the TriPlus 500 HS automated headspace sampler. It describes the different phases of the sampler's workflow including pressurization, injection, sampling, and purging. It also discusses parameters that can be set for each phase as well as considerations for temperature, carrier gas flow, auxiliary gas pressure, sample vials, shaking conditions, and more. The goal is to optimize the headspace sampler's settings and parameters to achieve the desired analytical sensitivity.
Slides presented at the Greater Cleveland R User Meetup group on the statistical concept of mediation using the lavaan package for structural equation modeling.
Using Fusion QbD as an Analytical Quality by Design Software for Method Devel...Waters Corporation
This presentation describes the benefits of a hardware and software platform that dramatically advances LC and LC-MS method development by applying Analytical Quality by Design (AQbD) approaches in a 100% regulatory compliance supported framework. This AQbD aligned platform includes Waters Empower™ Chromatography Data System Software with enhanced Fusion QbD® Software, the Waters® ACQUITY UPLC H-Class PLUS, a PDA detector, and QDa Mass Detector. New software capabilities that optimize and simplify the use of mass detection in the AQbD method development workflow have been added.
Visit methods.waters.com for more information
Regression analysis mathematically and statistically describes the relationship between a set of independent variables and a dependent variable. This presentation describes the concept of regression and its types with suitable illustrations. This presentation also explains the regression analysis spss path and its interpretations.
This presentation explains the procedure involved in two-way repeated measures ANOVA(within-within design). An illustration has been discussed by using the functionality of SPSS.
You want a flexible and multi-usable GC or GCMS system with increased application range and detection limits? From 1ul injection till automated pyrolysis GCMS.
This presentation discusses the procedure involved in two-way mixed ANOVA design. The procedure has been discussed by solving a problem using SPSS functionality.
Slides presented at the Greater Cleveland R User Meetup group on the statistical concept of mediation using the lavaan package for structural equation modeling.
Using Fusion QbD as an Analytical Quality by Design Software for Method Devel...Waters Corporation
This presentation describes the benefits of a hardware and software platform that dramatically advances LC and LC-MS method development by applying Analytical Quality by Design (AQbD) approaches in a 100% regulatory compliance supported framework. This AQbD aligned platform includes Waters Empower™ Chromatography Data System Software with enhanced Fusion QbD® Software, the Waters® ACQUITY UPLC H-Class PLUS, a PDA detector, and QDa Mass Detector. New software capabilities that optimize and simplify the use of mass detection in the AQbD method development workflow have been added.
Visit methods.waters.com for more information
Regression analysis mathematically and statistically describes the relationship between a set of independent variables and a dependent variable. This presentation describes the concept of regression and its types with suitable illustrations. This presentation also explains the regression analysis spss path and its interpretations.
This presentation explains the procedure involved in two-way repeated measures ANOVA(within-within design). An illustration has been discussed by using the functionality of SPSS.
You want a flexible and multi-usable GC or GCMS system with increased application range and detection limits? From 1ul injection till automated pyrolysis GCMS.
This presentation discusses the procedure involved in two-way mixed ANOVA design. The procedure has been discussed by solving a problem using SPSS functionality.
NDSRIs - Nitrosamine Drug Substance-Related Impurities (NDSRIs)Chandra Prakash Singh
NDSRIs impurities share structural similarity to the API (having the API or API fragment in the chemical structure) and are therefore unique to each API.
NDSRIs generally form in the drug product through nitrosation of APIs (or API fragments) that have secondary or tertiary amines when exposed to nitrosating agents such as residual nitrites in excipients used to formulate the drug product.
Generally, the presence of high levels of NDSRIs has been associated with drug products rather than APIs because NDSRI formation usually results from a reaction between the API or API fragment and nitrosating agents in the drug formulation.
However, NDSRIs can potentially form in APIs when nitrosating agents are present in the API manufacturing process or when APIs undergo processing steps that can potentially induce their formation such as fluid bed drying at an elevated temperature and jet milling because these can create favorable conditions in which nitrogen oxides can react with at-risk APIs.
NDSRIs often lack carcinogenicity and mutagenicity study data (typically from animal studies) from which an AI limit can be determined.
This guidance provides a recommended methodology for AI limit determination that uses structural features of NDSRIs to generate a predicted carcinogenic potency categorization and corresponding recommended AI limit that manufacturers and applicants can apply, in the absence of other FDA recommended AI limits, in their evaluations of approved and marketed drug products as well as products in development or under review by FDA.
Currently Identified Risk Factors for Presence of Nitrosamines.pptxChandra Prakash Singh
N-Nitrosamines can be formed when an amine and nitrosating agent are combined under favourable conditions although other generation pathways are also possible, such as e.g. oxidation and reduction processes from hydrazine-type compounds and N-nitro derivatives.
Root causes for N-nitrosamines in medicinal products identified to date can be grouped as risk factors linked exclusively with the manufacturing process and storage of active substance and/or as risk factors associated with manufacture and storage of the finished product.
Moreover, there are risk factors specifically linked to GMP aspects.
Basic Understanding of LCMS
Ion Optics Path and Parameters.
Mass spectrometry measures the mass-to-charge ratio of ions to identify unknown compounds, to quantify known compounds, and to provide information about the structural and chemical properties of molecules.
The mass spectrometer has a series of quadrupole filters that transmit ions according to their mass-to-charge (m/z) ratio.
When the energy of the accelerated electrons is higher than a certain threshold value (which depends on the metal anode), a second type of spectrum is obtained superimposed on top of the white radiation. It is called the characteristic radiation and is composed of discrete peaks.
The energy (and wavelength) of the peaks depends solely on the metal used for the target and is due to the ejection of an electron from one of the inner electron shells of the metal atom.
This results in an electron from a higher atomic level dropping to the vacant level with the emission of an X-ray photon characterised by the difference in energy between the two levels.
CHARACTERIZATION OF CRYSTALLINE AND PARTIALLY CRYSTALLINE SOLIDS BY X-RAY POWDER DIFFRACTION (XRPD)
USP <941>
Every crystalline phase of a given substance produces a characteristic X-ray diffraction pattern.
Diffraction patterns can be obtained from a randomly oriented crystalline powder composed of crystallites (crystalline regions within a particle) or crystal fragments of finite size.
Essentially three types of information can be derived from a powder diffraction pattern:
The angular position of diffraction lines (depending on geometry and size of the unit cell).
The intensities of diffraction lines (depending mainly on atom type and arrangement and preferred orientation within the sample.
Diffraction line profiles (depending on instrumental resolution, crystallite size, strain, and specimen thickness).
LCMS - Ion Optics Path and Parameters
Source and gas parameters: These parameters can change depending on the ion source used.
Compound parameters: These parameters consist mostly of voltages in the ion path. Optimal values for compound-dependent parameters vary depending on the compound being analyzed.
Resolution parameters: These parameters affect the resolution and calibration.
Detector parameters: These parameters affect the detector.
A divert valve allows you to switch portions of the mobile phase to waste before the mass spectrometer.
This is particularly important for the portion containing all the un-retained components – many of which are likely to be involatile and contaminate the source. If you really want to keep things clean use a divert valve to divert everything to waste except the compounds of interest.
The integrated diverter valve, which is located next to the ion source, can be plumbed in injector mode or diverter mode.
LCMS Interface
API techniques (ESI, APCI and APPI)
In LCMS, ions can be generated through either the continuous or pulsed (discontinuous) modes.
The three API techniques (ESI, APCI and APPI) that were introduced operates in the continuous mode, giving a constant flow/supply of ions to the MS.
On the other hand, the pulsed mode generates a discontinuous source of ions such as the Matrix-Assisted Laser Desorption/Ionization (MALDI).
Analytical control strategy - Part -4 : How the ACS Applies to the Product Lifecycle and How the modern concept of a lifecycle model can be applied to analytical procedures.
How the modern concept of a lifecycle model, which is based on process validation and described in ICH guidelines Q8, Q9, and Q10, can be applied to analytical procedures.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
Normal Labour/ Stages of Labour/ Mechanism of LabourWasim Ak
Normal labor is also termed spontaneous labor, defined as the natural physiological process through which the fetus, placenta, and membranes are expelled from the uterus through the birth canal at term (37 to 42 weeks
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
5. Injection Phase
Pressurization Phase
Thermostatting Phase
Balanced Pressure
Sampling Systems
Pressure/Loop
Systems
An automated system of this kind was first
introduced in 1967 by Bodenseewerk, the
German subsidiary of the Perkin-Elmer
Corporation.
6. Standby Condition
The sample loop is installed
between the ports 3 and 6 of the
sampling valve.
The standard volume of the loop is
1.0 mL.
The following optional sample
loops are available: 25 μL, 50 μL,
100 μL, 500 μL, and 3 mL.
7. If in the sampler method the
purging function has been
enabled, during the Standby
phase a constant flow of
purge gas is circulating in
the system.
Standby with Purge
8. Pressurization Phase Three types of pressurization can be
chosen:
Pressurization at constant
pressure: The pressure P2 is
controlled by EV1 in order to keep a
default pressure rate increase until P2
reaches the Pressurization Pressure
set.
Pressurization at defined pressure
rate increase: The pressure P2 is
controlled by EV1 in order to keep a
pressure rate increase set by the user
until P2 reaches the pressurization
pressure set.
Pressurization at defined
pressurization time: The pressure
P2 is controlled by EV1 in order to
keep a pressure rate increase defined
by (Pressure set-Pressure
initial)/Time, where the time is set by
the operator, until P2 reaches the
pressurization pressure set.
9. At this point the system closes
both EV1 and On/Off valves for
performing a Leak check on the
sample vial.
The duration of the Leak check
is 12 seconds.
Leak Check
11. Injection (Sampling) Phase
Injection mode: Standard, Enrichment, and
MHE.
Standard — Equilibrates the vial, fills the sample
loop (single extraction), then starts a run while
injecting the sample into the Back SSL injector of
the GC. The loading time of the vials into the
incubation oven is automatically calculated to
guarantee the same equilibration time for all the
samples, and the optimization of the analysis times.
According to the equilibration time and GC time,
more vials can be contemporaneously present inside
the incubation oven.
Enrichment — The sample from the same sample
vial is injected the number of time selected. The
parameters Additional injection and Enrichment
time are enabled.
MHE — Multiple Headspace Extraction. Each vial
is pressurized, sampled and vented multiple times.
Each vial is incubated first for a time equal to the
equilibration time set in the method, while the
incubation time of the subsequent samplings
corresponds to the longest time set in the method
(equilibration time or GC time). At each sampling
an analysis is performed.
12. Single Injection
The sample valve is set to inject position.
Send Start signal to the GC.
Venting phase (only if vial venting option is
selected).
The On/Off valve is open to vent the residual
pressure of the vial.
The sampling valve is set to load position when
injection time is expired.
The needle is removed from the vial.
MHE (Multiple Headspace Extraction)
Same as single injection, but venting is always
selected.
Enrichment
The sampling valve is set to Inject position.
The sampling valve is set to Load position when injection time is
expired.
The vial is removed from the sampling needle insertion position.
Repeat for N of enrichments -1.
Wait for enrichment time (shaking ON).
Pressurization.
Sampling.
The multi-position valve is set to inject position.
The multi-position valve is set to load position when injection time
is expired.
The needle is removed from the vial.
Last enrichment.
Send Start signal to the GC. The sampling valve is set to load
position when injection time is expired.
Venting phase (only if vial venting option is selected).
The On/Off valve is open to vent the residual pressure of the vial.
The sampling valve is in a position depending on the injection
time.
The needle is removed from the vial.
13. Purging Phase
The Purging is a post-
injection phase that starts after
the selected sampling phase is
completed.
This function allows to reduce
the carryover.
The sampling valve is in Load
position and the On/Off valve
is open. The pressure P2 is
controlled by EV1 to maintain
the purge flow level.
This phase ends the analytical
sequence.
14. Aux Pressure and Approximate Flow Values
Note:
Flow rates might change slightly depending on operational temperatures.
The purge level set for the post-injection purging is also applied to stand-by purge when selected.
If purging is not necessary, consider not checking this option to reduce gas consumption during stand-by.
15. Temperatures
The oven temperature can have a profound effect on the concentration of analyte that passes into the gas phase.
In general as the temperature increases, the amount of analyte in the gaseous phase increases, and consequently the
sensitivity of the method.
Consider the following when choosing the oven temperature:
The best results are achieved when the temperature is maintained at the minimum level sufficient to ensure the desired
analytical sensibility.
Do not set the oven temperature within 10 °C of the boiling point of any solvent, except in special cases.
Thermally labile compounds may degrade at elevated temperatures.
The sampling path temperatures must be equal to or higher than the oven temperature to avoid the condensation of the
analytes in the pneumatic system, and consequently avoid the presence of residuals.
Carrier Gas Optimization
The carrier gas flow rate should be set high enough to transfer the headspace sample out of the loop into the GC without
causing peak broadening.
For a capillary column that generates a 1-second-wide peak, the flow rate should be higher than 60 mL/min. In this case the
flow rate will be the total flow (column flow + split flow).
Auxiliary Gas Pressure Optimization
The pressure developed in the vial allows you to transfer the head space sample to the sample loop. The auxiliary gas
pressure should be set at the minimum value to ensure the loop filling.
To optimize your selection of vial pressurization, run a series of vials using different pressures, and interpret the optimum
condition from peak areas versus vial pressurization.
16. Sample Vials
A larger sample size may give greater sensitivity. Peak areas are influenced by the
relative amount of the gas and condensed phases in the vial.
If the sensitivity is not a fundamental requirement, small vials may be preferred
because a shorter equilibration time is required.
The bottom profile of a headspace vial may be round or flat. Generally a round-
bottomed vial tends to withstand higher pressures and is more suitable for elevated
temperature.
Sample Vial Septa
Use septa suitable for the temperature of the system. Poor septa can bleed and
contaminate the headspace.
The use of septa with the lower layer in PTFE is recommended to avoid
contamination of the sample. Always confirm that there are no peaks in the blank
analysis chromatogram.
Suggested septum thickness = minimum 2 mm.
Shaking Conditioning
In some cases, and especially for aqueous samples, shaking during the equilibration phase reduces the time required to
reach the equilibrium.
The shaking benefits samples with a larger amount of liquid, liquid samples with high viscosity, and analytes with high
partition coefficients K.
17. Vial Closure
A frequent, and non-negligible cause of error, is a
leak due to incorrect closure of the vial.
To close the vials, use a crimper then check each
vial for proper crimping.
The vial requires the use of a metallic cap.
If the cap is loose the vial may leak.
Adjust the crimper and close the vial again.
The cap should be flat.
Vial Filling
To avoid liquid droplets remain under the septum during shaking and to leave a
minimum head space volume, it is suggested to fill the vial with sample
according to the following limit.
Maximum 60% (6 mL) of the vial capacity for the 10 mL vial.
Maximum 75% (15 mL) of the vial capacity for the 20/22 mL vial.